GLP-1 pills are coming, and they could revolutionize weight-loss …
Sep 17, 2024 · At least a dozen experimental weight-loss drugs designed to be taken as pills are working their way through clinical trials, with the most advanced now in the third and final stage of testing.
Next-generation drug from Eli Lilly boosts weight loss to 24% ... - CNN
Jun 26, 2023 · Daily pill from Eli Lilly leads to 15% weight loss in midstage study, rivaling Wegovy results without the shot. These drugs mimic gut hormones to curb appetite and slow stomach emptying,...
What the results of Wegovy’s longest clinical trial yet show about ...
May 13, 2024 · CNN — New analyses of the longest clinical trial yet of the weight-loss drug Wegovy are shedding light on how quickly it helps people lose weight, how long they sustain that weight loss and how...
FDA approves Eli Lilly’s Zepbound, a weight loss drug ... - NBC News
Nov 8, 2023 · The Food and Drug Administration on Wednesday approved Zepbound, a new weight loss drug from drugmaker Eli Lilly that was shown in clinical trials to help people lose up to 52 pounds in 16...
What to know about Zepbound, Eli Lilly’s new weight loss drug - NBC News
Nov 9, 2023 · A new weight loss drug has been approved that promises to be the most effective medication yet. How is Zepbound, the weekly injectable drug that’s expected to be available shortly after...
Effective pills for weight loss, including an oral version ... - NBC News
Jun 26, 2023 · On Sunday, Novo Nordisk presented findings looking at an oral version of semaglutide — the active ingredient in Ozempic and Wegovy — for weight loss in people who are obese or overweight, and ...
FDA approves a new weight loss drug, Zepbound from Eli Lilly
Nov 9, 2023 · FDA approves Eli Lilly's Zepbound drug for weight loss 01:59. The Food and Drug Administration approved a request by Eli Lilly on Wednesday to begin marketing its tirzepatide medication, which is ...
The Race for the Next Ozempic | WIRED
Jul 24, 2024 · The San Diego company is testing both an injectable and pill form. In a trial of the injectable version, participants lost nearly 15 percent of their weight over 13 weeks.
What to Know About Zepbound, the New Weight Loss Drug - The New York Times
Nov 8, 2023 · The decision by the Food and Drug Administration on Wednesday to approve the weight loss drug tirzepatide adds a potent new tool to the fast-growing arsenal of obesity drugs.
New Oral Weight Loss Drugs: Where Are We and What's Next? - Medscape
Jun 5, 2024 · Novo Nordisk's spokesperson told Medscape Medical News that, as announced in March, results from an exploratory endpoint on body weight change in a phase 1 trial showed an average −13.1%...